Source: European Medicines Agency (EU) Revision Year: 2023 Publisher: Almirall, S.A., Ronda General Mitre, 151, 08022 Barcelona, Spain
Ebglyss 250 mg solution for injection in pre-filled syringe.
Ebglyss 250 mg solution for injection in pre-filled pen.
| Pharmaceutical Form |
|---|
|
Solution for injection (injection). Clear to opalescent, colourless to slightly yellow to slightly brown solution, free of visible particles. |
Ebglyss 250 mg solution for injection in pre-filled syringe: Each single-use pre-filled syringe contains 250 mg of lebrikizumab in 2 mL solution (125 mg/mL).
Ebglyss 250 mg solution for injection in pre-filled pen: Each single-use pre-filled pen contains 250 mg of lebrikizumab in 2 mL solution (125 mg/mL). Lebrikizumab is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Lebrikizumab |
Lebrikizumab is an immunoglobulin (IgG4) monoclonal antibody that binds with high affinity to interleukin (IL)-13 and selectively inhibits IL-13 signalling through the IL-4 receptor alpha (IL-4RĪ±)/ IL-13 receptor alpha 1 (IL-13RĪ±1) heterodimer, thereby inhibiting the downstream effects of IL-13. Inhibition of IL-13 signalling is expected to be of benefit in diseases in which IL-13 is a key contributor to the disease pathogenesis. Lebrikizumab does not prevent the binding of IL-13 to the IL-13 receptor alpha 2 (IL-13RĪ±2 or decoy receptor), which allows the internalisation of IL-13 into the cell. |
| List of Excipients |
|---|
|
Histidine |
2 mL solution in a 2.25 mL Type-1 clear glass pre-filled syringe with small round flange, with a 27 gauge special thin wall x 12.7 mm stacked stainless steel needle, closed with a laminated bromobutyl elastomeric plunger and a rigid needle shield and assembled in a passive safety device.
Pack sizes:
1 pre-filled syringe
2 pre-filled syringes
multipack containing 3 (3 packs of 1) single-dose pre-filled syringes
multipack containing 4 (2 packs of 2) single-dose pre-filled syringes
multipack containing 5 (5 packs of 1) single-dose pre-filled syringes
multipack containing 6 (3 packs of 2) single-dose pre-filled syringes
2 mL solution in a 2.25 mL Type-1 clear glass syringe in a pre-filled pen with extra-small round flange, with a 27 gauge special thin wall x 8 mm stacked stainless steel needle, and closed with a laminated bromobutyl elastomeric plunger and a rigid needle shield.
Pack sizes:
1 pre-filled pen
2 pre-filled pens
multipack containing 3 (3 packs of 1) single-dose pre-filled pens
multipack containing 4 (2 packs of 2) single-dose pre-filled pens
multipack containing 5 (5 packs of 1) single-dose pre-filled pens
multipack containing 6 (3 packs of 2) single-dose pre-filled pens
Not all pack sizes may be marketed.
Almirall, S.A., Ronda General Mitre, 151, 08022 Barcelona, Spain
EU/1/23/1765/001
EU/1/23/1765/002
EU/1/23/1765/003
EU/1/23/1765/004
EU/1/23/1765/005
EU/1/23/1765/006
EU/1/23/1765/007
EU/1/23/1765/008
EU/1/23/1765/009
EU/1/23/1765/010
EU/1/23/1765/011
EU/1/23/1765/012
| Drug | Countries | |
|---|---|---|
| EBGLYSS | Austria, Estonia, Croatia, Ireland, Italy, Lithuania, United Kingdom |
Ā© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
